Harder DR, Narayanan J, Gebremedhin D. Pressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood flow. Am J Physiol Heart Circ Physiol 300: H1557-H1565, 2011. First published January 21, 2011; doi:10.1152/ajpheart.01097.2010.-While myogenic force in response to a changing arterial pressure has been described early in the 20th century, it was not until 1984 that the effect of a sequential increase in intraluminal pressure on cannulated cerebral arterial preparations was found to result in pressure-dependent membrane depolarization associated with spike generation and reduction in lumen diameter. Despite a great deal of effort by different laboratories and investigators, the identification of the existence of a mediator of the pressure-induced myogenic constriction in arterial muscle remained a challenge. It was the original finding by our laboratory that demonstrated the capacity of cerebral arterial muscle cells to express the cytochrome P-450 4A enzyme that catalyzes the formation of the potent vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE) from arachidonic acid, the production of which in cerebral arterial muscle cells increases with the elevation in intravascular pressure. 20-HETE activates protein kinase C and causes the inhibition of Ca 2ϩ -activated K ϩ channels, depolarizes arterial muscle cell membrane, and activates L-type Ca 2ϩ channel to increase intracellular Ca 2ϩ levels and evoke vasoconstriction. The inhibition of 20-HETE formation attenuates pressureinduced arterial myogenic constriction in vitro and blunts the autoregulation of cerebral blood flow in vivo. We suggest that the formation and action of cytochrome P-450-derived 20-HETE in cerebral arterial muscle could play a critically important role in the control of cerebral arterial tone and the autoregulation of cerebral blood flow under physiological conditions. 20-hydroxyeicosatetraenoic acid; cytochrome P-450 4A; ion channels; membrane potential STEPWISE INCREASE OF transmural pressure in isolated and cannulated cerebral arteries gives rise to a series of signaling events that culminate in stepwise constriction of the arterial segments. These arterial muscle signaling events include membrane depolarization, reduction in outward K ϩ current, increase in inward Ca 2ϩ current (via L-type Ca 2ϩ channels), translocation of PKC and phosphorylation, and elevation of inositol 1,4,5-trisphosphate and diacylglycerol, all of which are related to the activation of arterial muscle and allow arterial diameter to track changes in blood pressure, thereby maintaining blood flow relatively constant (3, 5, 19, 25, (27) (28) (29) (30) (31) 44) . The signaling pathway mediating these events involves the production of the potent vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE) (15, 21, 23, 26, 34) . These series of signaling reactions maintain blood flow constant despite wide fluctuations in arterial pressure. The reasons for such maintenance of blood flow can be explained both physiologically as well as teleologically. The skull does not allow for changes in vascular volume or flow because of the physics of incompressible fluids in a confined space. The space available for the distribution of volume is necessary for changes in the vascular space and protection of the microcirculation from changes in blood pressure (2, 18). Similarly, changes in intravascular shear forces act to modify vascular diameter, thereby altering myogenic capacity and total intravascular volume (45, 46). The action of shear is considered limited to actions emanating from endothelial factors, whereas the action of pressure acts on both endothelial and arterial muscle cells, exerting influences that act to both constrict and dilate (19, 22, 44, 46) . While myogenic forces in response to a changing arterial pressure have been described early in the 20th century (3), it was not until 1984 (19) that we observed that increasing intravascular pressure depolarized the vascular wall, altering sensitivity to vasoactive agents via evoking changes in ionic conductance systems compared with the then
STEPWISE INCREASE OF transmural pressure in isolated and cannulated cerebral arteries gives rise to a series of signaling events that culminate in stepwise constriction of the arterial segments. These arterial muscle signaling events include membrane depolarization, reduction in outward K ϩ current, increase in inward Ca 2ϩ current (via L-type Ca 2ϩ channels), translocation of PKC and phosphorylation, and elevation of inositol 1,4,5-trisphosphate and diacylglycerol, all of which are related to the activation of arterial muscle and allow arterial diameter to track changes in blood pressure, thereby maintaining blood flow relatively constant (3, 5, 19, 25, (27) (28) (29) (30) (31) 44) . The signaling pathway mediating these events involves the production of the potent vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE) (15, 21, 23, 26, 34) . These series of signaling reactions maintain blood flow constant despite wide fluctuations in arterial pressure. The reasons for such maintenance of blood flow can be explained both physiologically as well as teleologically. The skull does not allow for changes in vascular volume or flow because of the physics of incompressible fluids in a confined space. The space available for the distribution of volume is necessary for changes in the vascular space and protection of the microcirculation from changes in blood pressure (2, 18). Similarly, changes in intravascular shear forces act to modify vascular diameter, thereby altering myogenic capacity and total intravascular volume (45, 46) . The action of shear is considered limited to actions emanating from endothelial factors, whereas the action of pressure acts on both endothelial and arterial muscle cells, exerting influences that act to both constrict and dilate (19, 22, 44, 46) . While myogenic forces in response to a changing arterial pressure have been described early in the 20th century (3), it was not until 1984 (19) that we observed that increasing intravascular pressure depolarized the vascular wall, altering sensitivity to vasoactive agents via evoking changes in ionic conductance systems compared with the then standard practice of mounting ring segments on wires connected to tension recording myographs (6). Depicted in Fig. 1 is the effect of a sequential increase in intraluminal pressure on cannulated cerebral arterial preparations that resulted in pressure-dependent membrane depolarization and reduction in lumen diameter. The stimulation of different types of lipases can catalyze hydrolytic cleavage and release arachidonic acid (AA) from the sin-2 position of membrane phospholipids (23, 44, 52, 53) . This enzymatically released AA can be metabolized to prostaglandins, leukotrienes, and, as mainly discussed in this review, to the cytochrome P-450 (CYP) (40, 41, 50) catalyzed metabolic products (7, 16, 23, 42, 47) . Numerous communications and many awards have been given for the discovery of the vascular CYP monooxygenases (CYP--hydroxylase and CYP-epoxygenase), which metabolize AA to 20-HETE and epoxyeicosatrienoic acids (EETs), respectively, and the soluble epoxide hydrolases that inactivate the EETs (9, 12, 14 -16, 21, 47). The major CYP 4A--hydroxylase metabolite of AA 20-HETE was first identified and detected in intact cerebral arteries in 1994 by the laboratories of Harder et al. (Fig. 2B) (21) , and its specific production was latter confirmed in isolated cerebral arterial muscle cells (16) (Fig. 2A) . 20-HETE was found to be one of the most potent vasoconstrictors yet identified. The reported physiological actions of the CYP metabolites of AA including 20-HETE are via modification of ion channel functions (9, 14, 16, 17, 21). 20-HETE was found to inhibit the activity of the large-conductance Ca 2ϩ -activated K ϩ channel (K Ca ) and to increase the influx of Ca 2ϩ through the activation of cerebral arterial L-type Ca 2ϩ channels (16, 21, 31) . In the late 1980s and early 1990s, we found that the production of 20-HETE mediates the myogenic response, representing a major discovery at this time (21, 26, 34) . It was found that 20-HETE had a profound action to depolarize and raise intracellular Ca 2ϩ in the vascular wall through its action on arterial K Ca and L-type Ca 2ϩ channels (Figs. 3 and 4II) (16, 21, 31) .
Release of Arachidonic

Role of PKC and the Mechanism of Action of 20-HETE in Cerebral Vascular Control
At this point in time we could only speculate that an increase in arterial pressure activated phospholipases via a stretch by the stimulation of molecules in the vessel wall (11, 23, 39, 44) . Even though we do not know the precise mechanism through which pressure induces the production of 20-HETE to initiate the myogenic response, we do know that PKC and perhaps inositol 1,4,5-trisphosphate are involved (11, 25, 29, 30, 39) . The vasoconstriction action of pressure can be linked to depolarization (19, 22) subsequent to the release of 20-HETE and the activation and translocation of PKC (15, 21, 26, 31, 34) . Stimulus-induced activation of phospholipase C, including via the action of pressure, is linked to the subsequent formation of diacylglycerol, AA, and its metabolites, which activate PKC (23, 39) , inhibit K Ca activity, and depolarize the plasma membrane, leading to the elevation of intracellular Ca 2ϩ concentration and activation of cerebral arterial muscle (16, 21, 31, 34) . Indeed, the dominant action of 20-HETE appears to be through the activation of PKC (31) . Major supporting evidence for this hypothesis is the finding that the inhibition of endogenous PKC using selective N-myristoylated PKC pseudosubstrate inhibitor peptide [Myr⌿PKC-I (19 -27) ] blocks 20-HETEinduced reduction of K Ca current recorded in cerebral vascular smooth muscle cells (Fig. 5) without imposing an independent action (31) . Similarly, PMA, a prototype activator of PKC, induced the inhibition of K Ca current in the same cerebral arterial muscle cells that was attenuated by the actions of the above-mentioned PKC pseudosubstrate inhibitor peptide, which is mimicked by 20-HETE (31) . The fact that Myr⌿PKC-I (19 -27) does not change whole cell K Ca current by itself compared with control indicates the involvement of PKC-mediated pathways in the 20-HETE-induced inhibition of K Ca current. Furthermore, biochemical data demonstrate that 20-HETE increases the phosphorylation of the myristoylated alanine-rich C kinase substrate (MARCKS), a sensitive and selective endogenous substrate and indicator of the level of PKC activity (Fig. 6 ), providing supportive evidence for the role of PKC as one of the molecular targets for the action of 20-HETE.
Important Role of 20-HETE in Pressure-Induced Myogenic Autoregulation
Many actions have been ascribed to effects of 20-HETE (15, 16, 31, 47) . One of the most important of these is the activation of PKC-induced phosphorylation (31) . This action of 20-HETE results in the inhibition of K Ca channel activity and membrane depolarization. Such membrane depolarization is responsible for a variety of signaling events, including the activation of L-type Ca 2ϩ channels and an increase in inward Ca 2ϩ current. We believe the membrane depolarization in response to the inhibition of K Ca channel activity creates a positive driving force for Ca 2ϩ influx and a very potent signal for cell activation. These findings have been duplicated in numerous publications (15, 16, 31, 47) and is a signature event in pressureinduced activation of cerebral arterial muscle as transmural pressure increases (16) . We also feel that this could also be one of the initiating mechanisms resulting in pressure-induced activation of cerebral arterioles. The pivotal role of the activation of PKC in the 20-HETE-induced K Ca channel inhibition and membrane depolarization was convincingly confirmed by the ability of 20-HETE to increase the phosphorylation of the MARCKS, a specific and sensitive endogenous target for phosphorylation induced by PKC activation, and by the similarity of the 20-HETE-induced inhibitory action on the K Ca channel to that induced by the selective PKC activator PMA (31; and references therein). It is presumed that such activation of PKC-associated MARCKS phosphorylation signaling pathway underlying the vasoconstrictor actions of 20-HETE could be a link for the interaction with other endogenous signaling molecules or genes containing a MARCKS domain and has the potential to influence membrane ionic events regulating myogenic responses in the cerebral circulation or in other vascular beds. Thus the 20-HETE PKC and MARCKS signaling pathway could be considered as a crucial signaling cascade for the assessment of brain function in health and/or in cerebrovascular disorders under different disease conditions.
Opposing Actions of CYP-Derived EETS on Pressure-Mediated Activation of 20-HETE: Ying-Yang Actions of Astrocytes and Possible Role in Functional Hyperemia
The expression of CYP 2C11 epoxygenase and the formation of EETs in primary cultures of astrocytes derived from cortical and hippocampal regions of the rat brain were first demonstrated in our laboratory by molecular and biochemical methods (1). Nearly a decade later, a second CYP epoxygenase isoform named CYP 4X1 was identified by Bylund et al. (7) in our laboratory in the rat, mouse, and human brain by reverse transcription polymerase chain reaction. CYP 4X1 was shown to be expressed in neurons throughout the brain, brain stem, hippocampus, cortex, and cerebellum, as well as vascular endothelial cells (7). Unlike 20-HETE, EETs increase the activity of K Ca channel currents and hyperpolarize cerebral and other arterial beds, leading to vasodilation (9, 14, 17, 20) . In the last 15 years since the findings of CYP 2C11 epoxygenase in astrocytes, a tremendous amount of work form numerous laboratories has led to the identification of many biological functions associated with EETs. Thus EETs have been shown to play a role in vascular cell proliferation, angiogenesis, anti-inflammation, antinociception, neuroprotection, and most importantly in vascular reactivity where they function to mediate functional hyperemia (9, 10, 14, 17, 43, 47, 49, 54, 57-59). Pressure-induced activation of cerebral arteries sets the stage for hyperemic increases in blood flow as EETs potently dilate the cerebral microcirculation supplying blood and oxygen to metabolically needy neurons. This scenario is depicted in Figs. 7 and 8 . In Fig. 8 , we present the membrane ying-yang depolarization mediated by 20-HETE and PKC (31) (depolarizing action) and the opposing hyperpolarizing action mediated by EETs (9, 14, 17). Figure 7 depicts the response and interaction of the entire neurovascular unit comprising neurons, astrocytes, and the microvasculature. Signals triggered by the metabolic demand of activated neurons will initiate a sequence of events equivalent to the recordings of brain activity by functional magnetic resonance imaging in which astrocyte-derived dilators such as EETs increase blood oxygenation and blood flow to match metabolic demand (20, 24, 49) . Such an occurrence of the sequence of events has been described in detail almost simultaneously by several laboratories, including ours (20, 24, 49).
Angiogenesis
The role of EETs with respect to the induction of angiogenesis in the central nervous system was first reported in cocultures of astrocytes and cerebral microvascular endothelial cells (37) . EETs released from astrocytes increased thymidine incorporation into endothelial cells and initiated the formation of tubelike capillary structures, which could be blocked by the CYP inhibitor 17-octadecynoic acid (37, 59) . Angiogenesis related to EETs was mediated by the release of these CYP epoxygenase metabolites of AA from astrocytes and could also be seen using synthetic plugs of Matrigel impregnated with EETs (59). This angiogenic process appears to involve the tyrosine kinase pathway based on the observation that genistein, a tyrosine kinase inhibitor, markedly attenuates this process (59) . Other laboratories using in vivo and in vitro methods have confirmed the role of EETs in angiogenesis (57, 58) . Other pathways through which EETs induce angiogenesis include MEK/MAPK, inositol phosphoinositide-3 kinase (PI3K)-Akt, and sphignosine kinase-1 signaling pathways (57, 58) . When cultured with astrocytes, cerebral capillary endothelial cells can form intact vascular circuits including arterioles, capillaries, and a blood brain barrier (Fig. 9) (59) .
The Entire Myogenic Cascade in Cerebral Arterioles
One look at the cascade of signaling and second messenger molecules identified thus far makes it clear why we have been working on the mechanisms responsible for the pressureinduced autoregulation of cerebral blood flow for over 100 years (3). The exponential rise in the generation of reagents and methods to define such pathways has allowed us to understand many of the mechanisms responsible in providing adequate blood flow to metabolically active neurons. Figure 10 depicts our current understanding relating the function of ion channels, regulation of membrane potential, and the myriad of signaling molecules that sense and transduce changes in blood pressure (5, 11, 13, 15, 19, 22, 25, 27-31, 39, 44, 48) . We, in collaboration with the laboratories of Dr. Richard Roman (University of Mississippi) and Dr. Howard Jacobs and other geneticists at the Medical College of Wisconsin developed a rat model to define the physiological and molecular mechanisms of pressure-induced autoregulation of cerebral blood flow. Two of the genes we have defined as having relative importance in this regard code for adducin-3 (ADD-3) and dual-specificity protein phosphatase (DUSP)-5 genes.
DUSP-5, a member of the DUSP gene family, targets and causes dephosphorylation of molecules such as activated MAPK, ERK, JNK, phosphatase and tensin homologues deleted on chromosome 10 and regulator of Akt (PTEN), and P38 (a form of mitogen-activated protein kinase) (33, 38) , critical signaling molecules also known to be involved in pressure-or stretch-induced myogenic responses (33, 38, 55) . The other gene of interest is the ADD-3 gene, which similar to the DUSP-5, is also expressed in brain tissue and cerebral vessels (unpublished findings), functions to promote the spectrin-actin binding, and controls the rate of actin polymerization by capping actin filaments at the plasma membrane (35, 36) , thereby in a position to initiate myogenic response. Adducin function is Ca 2ϩ and calmodulin dependent and contains the MARCKS domain (35, 36) , which is a target for phosphorylation by a family of kinases including PKC, tyrosine kinase, and [Rho]-kinase, or similar molecules that are important in signaling pressure-or stretch-induced myogenic responses (13, 25, 29, 30, 38, 55) . Despite the fact that very little is known about the functional roles of DUSP-5 and ADD-3 genes in vasoregulation, it is important that we study and unravel the potential roles of the ADD-3 and DUSP-5 genes in the development and maintenance of pressure-induced myogenic autoregulation in the cerebral circulation. As we learn more about these genes and other molecules associated with them, our knowledge of the mechanisms controlling the myogenic autoregulation of blood flow in normal and disease states will be enhanced. 
Summary
Since the early work of Bayliss (3), we have known that the blood vessel wall is capable of adapting to changes in transmural pressure. In 1984, Harder (19) elucidated the fact that increasing transmural pressure across the vessel wall induces membrane depolarization by reducing outward K ϩ current and increasing inward Ca 2ϩ current through L-type Ca 2ϩ channels. As discussed above, numerous second messengers could participate in initiating the signaling events that are at the heart of regulating myogenic tone, adjusting diameter through feedback mechanisms to maintain flow constant and adequate to meet neuronal metabolic demands. This review covers The 2009 Wiggers Lecture, sponsored by the Cardiovascular Section of the American Physiological Society. We have not presented the bulk of what was said during the lecture because of its preliminary and proprietary nature. Dr. David R. Harder is deeply honored to be awarded to give this prestigious lecture. The American Physiological Society has a long and rich history and has become the epitome of the concept "encompass use of all disciplines and techniques to answer questions related to the physiological function of living organisms." 
